CORAL LABORATORIES LTD.
Latest filings
- Quarterly share demat compliance certificate filed with BSE · Compliance
- AGM results: all 6 resolutions cleared, dividend approved · Board & Shareholder Meetings
- Coral Laboratories 44th AGM: 6 resolutions passed, final dividend declared · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹86 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from CORAL LABORATORIES LTD.'s filed financials and exchange disclosures
What does CORAL LABORATORIES LTD. do?
CORAL LABORATORIES LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.
Is CORAL LABORATORIES LTD. profitable?
Yes. Over the trailing twelve months CORAL LABORATORIES LTD. reported a net profit of ₹16 Cr on revenue of ₹86 Cr.
Does CORAL LABORATORIES LTD. pay a dividend?
Yes. The dividend yield is 0.30% at the current price. It paid out 3% of its profit as dividend in FY26.
Is CORAL LABORATORIES LTD. debt-free?
No. It reported borrowings of ₹4.33 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹2.96 Cr after cash. Debt stands at 0.02× equity. That is lower than 69% of its 166 Pharmaceuticals peers.
Is CORAL LABORATORIES LTD. expensive compared with its peers?
On trailing P/E, CORAL LABORATORIES LTD. ranks 23 of 158 in Pharmaceuticals — cheaper than 86% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the CORAL LABORATORIES LTD. share price move in a day?
On a typical session CORAL LABORATORIES LTD. moves 1.55% — that is the median absolute close-to-close move across its last 266 trading days. MarketPing measures each filing's price reaction against it.
Where can I track CORAL LABORATORIES LTD.'s announcements?
Every NSE and BSE filing by CORAL LABORATORIES LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.